Literature DB >> 26310668

Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells.

Rong-Jing Zhou1, Xiong-Ying Xu1, Bu-Xing Liu1, Wen-Zhen Dai1, Mei-Qin Cai1, Chun-Feng Bai1, Xian-Fei Zhang1, Li-Min Wang1, Li Lin1, Shu-Zhen Jia1, Wen-Hua Wang1.   

Abstract

The constitutive activation of signal transducer and activator of transcription 3 (STAT3) contributes to resistance to temozolomide (TMZ) in glioblastoma multiforme (GBM). The aim of this study was to explore the biological role of microRNA-31 (miR-31) in GBM, particularly its role in the regulation of TMZ chemosensitivity. For this purpose, the human GBM cell lines, U251 and U87, were transfected with a miR-31 precursor (pre-miR-31), and cell proliferation, apoptosis and STAT3 phosphorylation were then assessed. To evaluate the effects of miR-31 on TMZ cytotoxicity, the cells were transfected with pre-miR-31 and exposed to 100 µM TMZ for 72 h prior to cell proliferation and apoptosis analysis. A constitutively active STAT3 mutant was co-transfected with pre-miR-31 into the cells to confirm the mediating role of STAT3 signaling. The enforced expression of miR-31 significantly reduced cell proliferation and induced mitochondrial apoptosis, as manifested by the loss of mitochondrial membrane potential and the increase in caspase-9 and caspase-3 activity. The phosphorylation level of STAT3 was significantly decreased by the overexpression of miR-31. The co-delivery of the constitutively active STAT3 mutant blocked the tumor suppressive effects of miR-31. In addition, miR-31 overexpression significantly enhanced the cytotoxic effects of TMZ on the GBM cells, as evidenced by the accelerated suppression of cell proliferation and the induction of apoptosis. The chemosensitizing effects of miR-31 were significantly impaired by the expression of the constitutively active STAT3 mutant. Taken together, our results indicate that miR-31 triggers mitochondrial apoptosis and potentiates TMZ cytotoxicity in GBM cells largely through the suppression of STAT3 activation. Thus, the restoration of miR-31 expression may be of therapeutic beenefit in the treatment of GBM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26310668     DOI: 10.3892/ijmm.2015.2312

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

Review 1.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

2.  miR-31 promotes neural stem cell proliferation and restores motor function after spinal cord injury.

Authors:  Xiao Li; Yuantao Gao; Feng Tian; Ruochen Du; Yitong Yuan; Pengfei Li; Fang Liu; Chunfang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-09

3.  Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.

Authors:  Wei Zhou; Libo Liu; Yixue Xue; Jian Zheng; Xiaobai Liu; Jun Ma; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2017-03-13       Impact factor: 5.639

4.  Artificial microenvironment of in vitro glioblastoma cell cultures changes profile of miRNAs related to tumor drug resistance.

Authors:  Monika Witusik-Perkowska; Magdalena Zakrzewska; Dariusz J Jaskolski; Pawel P Liberski; Janusz Szemraj
Journal:  Onco Targets Ther       Date:  2019-05-20       Impact factor: 4.147

Review 5.  MicroRNAs: emerging driver of cancer perineural invasion.

Authors:  Mei Zhang; Hong-Chun Xian; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cell Biosci       Date:  2021-06-29       Impact factor: 7.133

6.  Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.

Authors:  Neha Singh; Alexandra Miner; Lauren Hennis; Sandeep Mittal
Journal:  Cancer Drug Resist       Date:  2021-03-19

Review 7.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

8.  miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1.

Authors:  Junjie Xiao; Hui Liu; Dragos Cretoiu; Daniela Oana Toader; Nicolae Suciu; Jing Shi; Shutong Shen; Yihua Bei; Joost Pg Sluijter; Saumya Das; Xiangqing Kong; Xinli Li
Journal:  Exp Mol Med       Date:  2017-10-20       Impact factor: 8.718

9.  Interaction of hematopoietic CD34+ CD45+ stem cells and cancer cells stimulated by TGF‑β1 in a model of glioblastoma in vitro.

Authors:  Elena Milkina; Arina Ponomarenko; Maria Korneyko; Irina Lyakhova; Yulia Zayats; Sergey Zaitsev; Polina Mischenko; Marina Eliseikina; Yuri Khotimchenko; Valeryi Shevchenko; Hari Sharma; Igor Bryukhovetskiy
Journal:  Oncol Rep       Date:  2018-08-24       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.